FALSE000006674000000667402022-05-212022-05-210000066740us-gaap:CommonStockMemberexch:XNYS2022-05-212022-05-210000066740us-gaap:CommonStockMemberexch:XCHI2022-05-212022-05-210000066740mmm:Notes0950PercentDue2023Memberexch:XNYS2022-05-212022-05-210000066740mmm:Notes1500PercentDue2026Memberexch:XNYS2022-05-212022-05-210000066740mmm:Notes1750PercentDue2030Memberexch:XNYS2022-05-212022-05-210000066740mmm:Notes1.500PercentDue2031Memberexch:XNYS2022-05-212022-05-21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 21, 2022
3M COMPANY
(Exact Name of Registrant as Specified in Its Charter)
| | | | | | | | | | | | | | |
Delaware | | File No. 1-3285 | | 41-0417775 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| | | | |
3M Center, St. Paul, Minnesota | | | | 55144-1000 |
(Address of Principal Executive Offices) | | | | (Zip Code) |
(Registrant’s Telephone Number, Including Area Code) (651) 733-1110
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| | | | | |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, Par Value $.01 Per Share | | MMM | | New York Stock Exchange |
| | MMM | | Chicago Stock Exchange, Inc. |
0.950% Notes due 2023 | | MMM23 | | New York Stock Exchange |
1.500% Notes due 2026 | | MMM26 | | New York Stock Exchange |
1.750% Notes due 2030 | | MMM30 | | New York Stock Exchange |
1.500% Notes due 2031 | | MMM31 | | New York Stock Exchange |
Note: The common stock of the Registrant is also traded on the SWX Swiss Exchange.
Securities registered pursuant to section 12(g) of the Act: None
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(b) Mojdeh Poul, Group President, Health Care Business Group (HCBG), has announced her intention to retire from 3M, effective July 1, 2022. The Company announced today that Jeff Lavers, currently Group President, Consumer Business Group, will also lead HCBG on an interim basis. 3M is conducting a comprehensive search for the Health Care Business group president role. Ms. Poul is one of the named executive officers included in 3M’s 2022 proxy statement filed on March 23, 2022.
Throughout her 11-year career with 3M, Ms. Poul consistently built and led high-performing teams, focused on key strategic imperatives, to deliver results through active portfolio management, value-creating innovation, and disciplined prioritization and capital allocation. With her leadership, the Company made significant progress on transforming its Health Care portfolio, positioning it for long-term, sustainable growth. Ms. Poul also has been an engaged sponsor to the Company’s employee resource networks and a passionate advocate of 3M’s Health Equity initiative.
Prior to his responsibility for the Consumer Business Group, Mr. Lavers led the Automotive and Aerospace Solutions Division, within the Transportation and Electronics Business Group, and led our oral care business, within our HCBG. He joined 3M in 1987 and has held roles with increasing responsibility with many years of demonstrated success as both a functional and business leader at 3M.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | |
| 3M COMPANY |
| |
| By: | /s/ Michael M. Dai |
| | |
| | Michael M. Dai |
| | Vice President, Associate General Counsel & Secretary |
Dated: May 24, 2022